Related Experiment Video
Updated: Jun 10, 2025

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Catheter-Directed Thrombolysis in the Management of Thrombotic Peripheral Artery Occlusions-Acute and Mid-Term
Ulrich Beschorner1, Tanja Boehme1, Elias Noory1
1University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Südring 15, 79189 Bad Krozingen, Germany.
Insights
Catheter-directed thrombolysis (CDT) effectively treats peripheral artery disease but carries a high risk of serious adverse events, particularly bleeding complications. Advanced age, alprostadil use, and longer lysis duration increase these risks.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiovascular Medicine
Background:
- Symptomatic peripheral artery disease (PAD) poses significant clinical challenges.
- Catheter-directed thrombolysis (CDT) is an endovascular option for PAD.
- Real-world data on CDT safety and efficacy in PAD is crucial.
Purpose of the Study:
- To evaluate the safety and efficacy of CDT using recombinant tissue plasminogen activator (rt-PA) in real-world PAD practice.
- To identify predictors of serious adverse events (SAEs) and specific complications like bleeding and reperfusion edema/compartment syndrome.
- To assess limb salvage and target lesion revascularization (TLR) rates following CDT.
Main Methods:
- Retrospective analysis of 1238 consecutive patients treated with CDT between 2013 and 2020.
- Primary endpoint: rate of SAEs until discharge.
- Secondary endpoints: interventional success, bleeding, reperfusion edema/compartment syndrome, limb salvage, and TLR.
Main Results:
- CDT was successful in 95.1% of patients.
- SAEs occurred in 41.3% (314 bleeding complications, 95 reperfusion edema/compartment syndrome).
- Amputation occurred in 42 patients; 33 patients died. Age, abciximab/alprostadil use, and lysis duration predicted SAEs and bleeding.
Conclusions:
- CDT is an effective endovascular treatment for thrombotic PAD.
- The procedure is associated with a high complication rate.
- Increasing age, alprostadil use, and lysis duration are independent risk factors for SAEs and bleeding.
Abstract:
Objectives: To evaluate the safety and efficacy of catheter-directed thrombolysis (CDT) with the recombinant tissue plasminogen activator (rt-PA) in all patients with symptomatic peripheral artery disease in real world practice. Methods: Consecutive patients treated with CDT between January 2013 and December 2020 were included in this retrospective analysis. The primary endpoint was the rate of serious adverse events (SAEs) until discharge. Secondary endpoints included interventional success, predictors for SAEs, bleeding and reperfusion edema/compartment syndrome, limb salvage, and clinical outcomes including target lesion revascularization rate (TLR). Results: Overall, 1238 patients were treated with CDT. SAEs occurred in 511 (41.3%) of the patients, 314 (25.4%) being bleeding complications. There were 95 cases of reperfusion edema/compartment syndrome. Forty-two patients underwent amputation and 33 patients (2.7%) died. CDT was successful in 1177 cases (95.1%). Multivariate logistic regression analysis identified age, abciximab and alprostadil usage, and lysis duration as predictors for SAEs and the use of abciximab as a predictor of reperfusion edema/compartment syndrome. Predictors for bleeding were age, alprostadil usage, and lysis duration. At 12 and 24 months, the limb salvage rate was 91.6% and 88.8%, and TLR rate was 46% and 57.2%, respectively. Conclusions: CDT is an effective endovascular method for the treatment of thrombotic peripheral artery occlusions but is associated with a high complication rate. For SAEs in general and bleeding specifically, increasing age, alprostadil use, and lysis duration were independent risk factors.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

